SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Taro Pharmaceutical Ind. (NasdaqNM:TARO) -- Ignore unavailable to you. Want to Upgrade?

To: Sleepman who wrote (4)3/13/2000 10:28:00 AM
From: FRANK J CATALANO  Read Replies (1) | Respond to of 18
 
DAN
TARO - DRUG STOCKS HAVE BEEN GETTING HIT . BUT TARO HAS
COME IN WITH STRONG ### YEAR AFTER YEAR FOR THE PAST
THREE YEARS . IF THEY CAN EARN AT LEAST +.75 THIS YEAR
THE STOCK SHOULD BE WORTH AT LEAST $18-$20. LETS KEEP A
CLOSE EYE ON THEIR FIRST QUARTER. MARCH 2000 !!
BEST OF LUCK CAT



To: Sleepman who wrote (4)4/9/2000 7:54:00 PM
From: Ed Ajootian  Read Replies (1) | Respond to of 18
 
Dan,

If these guys can find a way to break into the US Warfarin market they will be very successful. I believe the market is leery of this stock but I couldn't resist and bought a small amount of it recently at $10.50.

I believe 1Q is the first full quarter they were authorized to market Warfarin in the US. Should be interesting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News